Fifth Third Bancorp
SGP icon

Fifth Third Bancorp’s SpyGlass Pharma SGP Stock Holding History

Fifth Third Bancorp’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.48K Buy
+57
New +$1.4K ﹤0.01% 4142

Other funds holding SGP

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Fifth Third Bancorp's SGP Position: Q3 2026 in Review

Fifth Third Bancorp opened a new position in SpyGlass Pharma (SGP) in Q3 2026: 57 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #4142 among its holdings.

26 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Fifth Third Bancorp held 57 shares of SpyGlass Pharma worth $1.48K as of Q3 2026.
  • SpyGlass Pharma was a new Fifth Third Bancorp position in Q3 2026.
  • SpyGlass Pharma made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q3 2026, its #4142 holding.
  • 26 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Fifth Third Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.